Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LAG3 Antikörper

Dieser Maus Monoklonal Antikörper detektiert spezifisch LAG3 in ELISA. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN6937766
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für LAG3 Antikörper (ABIN6937766)

Target

Alle LAG3 Antikörper anzeigen
LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Reaktivität

  • 145
  • 43
  • 10
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 67
  • 53
  • 25
  • 13
  • 4
  • 1
  • 1
Maus

Klonalität

  • 108
  • 53
  • 2
Monoklonal

Konjugat

  • 89
  • 10
  • 8
  • 6
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser LAG3 Antikörper ist unkonjugiert

Applikation

  • 74
  • 51
  • 44
  • 40
  • 29
  • 24
  • 15
  • 13
  • 13
  • 12
  • 11
  • 9
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA

Klon

LAG3-3261
  • Verwendungszweck

    Lymphocyte Activation Gene 3 (LAG-3) (Negative Checkpoint Regulator) Antibody

    Spezifität

    LAG-3 (also called CD223) is a high affinity MHC class II ligand present on the surface of CD4+CD8+ T cells and NK cell, with shared homology in structure to CD4 molecules. It has a glutamic acid-proline (EP) repetitive sequence found in other functionally distinct mammalian, parasitic, and bacterial proteins that may influence a conserved biological function. LAG-3+CD4+CD8+ T cells can associate with the T cell receptor (TCR) and downregulate TCR signaling in vitro. LAG-3 inhibits CD4-dependent T cell function via its cytoplasmic domain. LAG-3 Lys-468 within a conserved 'KIEELE' motif is essential for interaction with downstream signaling molecules. Furthermore, as a checkpoint inhibitor target, it may be superior to CTLA-4 and PD-1 since both antibodies only activate effector T-cells, whereas an antagonist LAG-3 antibody can both activate T effector cells (by downregulating the LAG-3 inhibiting signal into pre-activated LAG-3+ cells) and inhibit induced (i.e. antigen-specific) Treg suppressive activity.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human LAG3 protein

    Isotyp

    IgG2a, kappa
  • Applikationshinweise

    Known_Application: ELISA (Use Ab at 2-4ug/ml for coating) (Order Ab without BSA); Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil or Hodgkin's lymphoma (IHC-P).

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Andere Bezeichnung

    LAG3

    Hintergrund

    CD223; FDC protein; LAG-3

    Human tonsil or Hodgkin's lymphoma (IHC-P).

    Molekulargewicht

    70kDa

    Gen-ID

    3902, 409523

    UniProt

    P18627

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Sie sind hier:
Chat with us!